These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15602026)

  • 1. Oral mucositis--the search for a solution.
    Garfunkel AA
    N Engl J Med; 2004 Dec; 351(25):2649-51. PubMed ID: 15602026
    [No Abstract]   [Full Text] [Related]  

  • 2. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
    Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
    N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palifermin and chemotherapy-induced oral mucositis.
    Palmieri C; Vigushin D
    N Engl J Med; 2005 Mar; 352(12):1264-5; author reply 1264-5. PubMed ID: 15791703
    [No Abstract]   [Full Text] [Related]  

  • 4. Palifermin and chemotherapy-induced oral mucositis.
    Köstler WJ; Hejna M; Zielinski CC
    N Engl J Med; 2005 Mar; 352(12):1264-5; author reply 1264-5. PubMed ID: 15791702
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.
    Scully C; Epstein J; Sonis S
    Head Neck; 2003 Dec; 25(12):1057-70. PubMed ID: 14648865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palifermin and chemotherapy-induced oral mucositis.
    Awada A; Genot MT; Klastersky J
    N Engl J Med; 2005 Mar; 352(12):1264-5; author reply 1264-5. PubMed ID: 15788506
    [No Abstract]   [Full Text] [Related]  

  • 7. Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?
    Sonis ST
    Nat Clin Pract Oncol; 2005 Mar; 2(3):134-5. PubMed ID: 16264905
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer therapy-related oral mucositis.
    Redding SW
    J Dent Educ; 2005 Aug; 69(8):919-29. PubMed ID: 16081575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palifermin (Kepivance) for myelotoxic-therapy-related mucositis.
    Med Lett Drugs Ther; 2005 Apr; 47(1207):36. PubMed ID: 15843784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and management of oral complications associated with cancer therapies: radiotherapy/chemotherapy.
    Toth BB; Chambers MS; Fleming TC
    Tex Dent J; 1996 Jun; 113(6):23-9. PubMed ID: 9518843
    [No Abstract]   [Full Text] [Related]  

  • 11. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
    Radtke ML; Kolesar JM
    J Oncol Pharm Pract; 2005 Sep; 11(3):121-5. PubMed ID: 16390600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral mucositis therapy comes of age.
    Stiff PJ
    J Support Oncol; 2005; 3(2 Suppl 1):73-5. PubMed ID: 15794501
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention and management of oral mucositis induced by antineoplastic therapy.
    Sonis S; Clark J
    Oncology (Williston Park); 1991 Dec; 5(12):11-8; discussion 18-22. PubMed ID: 1840018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
    Freytes CO; Ratanatharathorn V; Taylor C; Abboud C; Chesser N; Restrepo A; Arango J; Odenheimer D
    Clin Cancer Res; 2004 Dec; 10(24):8318-24. PubMed ID: 15623608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis - are there new strategies?
    Karthaus M; Rosenthal C; Ganser A
    Bone Marrow Transplant; 1999 Nov; 24(10):1095-108. PubMed ID: 10578160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.
    Demarosi F; Bez C; Carrassi A
    Minerva Stomatol; 2002 May; 51(5):173-86. PubMed ID: 12070468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical mesalazine in the treatment of chemotherapy and radiotherapy-induced oral mucositis.
    Rymes N; Glick L; Holmes JA
    Bone Marrow Transplant; 1996 Aug; 18(2):484. PubMed ID: 8864473
    [No Abstract]   [Full Text] [Related]  

  • 18. New strategies for management of oral mucositis in cancer patients.
    Peterson DE
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):9-13. PubMed ID: 16499139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mucositis--a major non-hematologic complication of high-dose chemotherapy and radiotherapy--pathogenesis, prevention and treatment].
    Piatkowska-Jakubas B; Darczuk D; Chomyszyn-Gajewska M; Skotnicki AB
    Przegl Lek; 2003; 60(12):815-20. PubMed ID: 15058023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice.
    Dörr W; Bässler S; Reichel S; Spekl K
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):881-7. PubMed ID: 15936573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.